JTL Stock Overview
Jayex Technology Limited provides healthcare industry service technologies in Australia and the United Kingdom.
Capture your thoughts, links and company narrative
Jayex Technology Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.01|
|52 Week High||AU$0.013|
|52 Week Low||AU$0.004|
|1 Month Change||0%|
|3 Month Change||11.11%|
|1 Year Change||42.86%|
|3 Year Change||-56.52%|
|5 Year Change||-54.55%|
|Change since IPO||-96.61%|
Recent News & Updates
|JTL||AU Healthcare Services||AU Market|
Return vs Industry: JTL exceeded the Australian Healthcare Services industry which returned 28.4% over the past year.
Return vs Market: JTL exceeded the Australian Market which returned -3.3% over the past year.
|JTL Average Weekly Movement||19.3%|
|Healthcare Services Industry Average Movement||9.4%|
|Market Average Movement||8.5%|
|10% most volatile stocks in AU Market||15.6%|
|10% least volatile stocks in AU Market||3.2%|
Stable Share Price: JTL is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 19% a week.
Volatility Over Time: JTL's weekly volatility has decreased from 25% to 19% over the past year, but is still higher than 75% of Australian stocks.
About the Company
Jayex Technology Limited provides healthcare industry service technologies in Australia and the United Kingdom. It offers Jayex Connect, a patient engagement platform that offers tools to manage patient experience and engagement comprising APPOINTUIT for online appointment booking; DISPLAY for transforming waiting room with digital displays; ARRIVE for patient self-check-in; and Jayex Survey that provides a toolkit for designing and publishing custom patient questionnaires. The company was formerly known as Jayex Healthcare Limited and changed its name to Jayex Technology Limited in May 2021.
Jayex Technology Limited Fundamentals Summary
|JTL fundamental statistics|
Is JTL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|JTL income statement (TTM)|
|Cost of Revenue||AU$4.02m|
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.021|
|Net Profit Margin||-133.89%|
How did JTL perform over the long term?See historical performance and comparison